Cleveland Clinic Launches New RPM and Tele-ICU Initiative with Masimo
Cleveland Clinic is teaming up with Masimo on a new partnership focused on hospital-based remote patient monitoring and virtual intensive care.
WHY IT MATTERS
According to the company, the work includes integrating Cleveland Clinic’s core critical care and non-critical care patient monitoring platforms with Masimo’s hospital automation platform, providing clinicians with tools that “deliver enhanced situational awareness and clinical decision support for hospitalized patients, including critically ill patients.”
The health system will also collaborate with the vendor on initiatives around predictive analytics and other AI-based algorithms, with a special focus on cardiology, they say.
Cleveland Clinic already has a central monitoring platform for critical care and non-critical care, which allows for continuous monitoring of vital signs for both critical care and non-critical care patients. RPM programs are in place for 11 hospitals, providing critical care monitoring, 24/7 critical care nursing, and patient management.
Masimo’s hospital automation platform, meanwhile, is built around tools designed to help clinicians improve care not just at the bedside, but wherever the patient may be in the care continuum. These technologies include monitoring and wearable sensors, high-fidelity medical device integration, surveillance and data visualization applications, and other AI technologies to help clinicians triage patients and recognize changes in their condition more quickly and efficiently.
They are powered by the company’s Halo engine, “which identifies patterns of deterioration across multiple physiological parameters simultaneously,” Masimo said.
Cleveland Clinic will work with the developer to jointly develop other Halo-based decision support tools to help clinicians detect adverse events earlier in patients across a wide range of acuities. With Masimo, the health system also aims to bring its innovations and patient benefits “to other health systems in the future,” the company said in a press release.
ON THE RECORD
“We look forward to exploring the effects of next-generation wearable devices in the hospital setting and, as AI capabilities continue to evolve, studying the potential impact on the care of cardiac patients, including those undergoing cardiac surgery,” said Dr. Thomas Callahan, a cardiologist at the Cleveland Clinic’s Heart, Vascular & Thoracic Institute and principal investigator for the AI study, in a statement.
“By combining Masimo’s AI-based decision support tools, automation solutions and monitoring devices with Cleveland Clinic’s deep clinical expertise and commitment to providing the highest quality, most innovative care, our partnership can significantly reduce staffing shortages, better standardize care and advance care led by intensivists and specialists,” said Joe Kiani, founder and CEO of Masimo.
Mike Miliard is Editor-in-Chief of Healthcare IT News
Email the author: mike.miliard@himssmedia.com
Healthcare IT News is a publication of HIMSS.
The HIMSS AI in Healthcare Forum will take place September 5-6 in Boston. More information and registration.